Wang, Bruce <br/><br/>
The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United States.  [electronic resource] 

 -  PloS one  2015 
 - e0121915 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0121915  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cost-Benefit Analysis<br/>Decision Support Techniques<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Exenatide<br/>Female<br/>Humans<br/>Liraglutide--administration & dosage<br/>Male<br/>Models, Economic<br/>Peptides--administration & dosage<br/>United States<br/>Venoms--administration & dosage